SHANGHAI SINOBIOWAY SUNTERRA BIOTECHNOLOGY
Shanghai Sinobioway Sunterra Biotechnology focuses on cutting-edge biotechnology, specifically in the field of adoptive cellular therapies. It was formed by Sinobioway Group, Sunterra Capital, and F1 Oncology for the express purpose of developing novel CAB-CAR-T therapies for solid tumor malignancies in China. SSSB's GMP cell processing facilities in Shanghai have been developed to support clinical research through key academic collaborations.
SHANGHAI SINOBIOWAY SUNTERRA BIOTECHNOLOGY
Status:
Active
Contact:
021-63916608
Technology used in webpage:
Nginx
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2018-01-08 | Exuma Biotech | Shanghai Sinobioway Sunterra Biotechnology investment in Venture Round - Exuma Biotech | 10 M USD |
More informations about "Shanghai Sinobioway Sunterra Biotechnology"
Shanghai Sinobioway Sunterra Biotechnology - CB Insights
May 21, 2019 Shanghai Sinobioway Sunterra Biotechnology focuses on cutting-edge biotechnology, specifically in the field of adoptive cellular therapies. The core business of the …See details»
Shanghai Sinobioway Sunterra Biotechnology Co., Ltd. - CMOCRO
Shanghai Sinobioway Sunterra Biotechnology Co., Ltd. focuses on biotechnology, specifically field of adoptive cellular therapies. By investing in and building the GMP facility for virus packaging …See details»
Shanghai Sinobioway Sunterra Biotechnology - Investments, …
Jan 8, 2018 Shanghai Sinobioway Sunterra Biotechnology focuses on cutting-edge biotechnology, specifically in the field of adoptive cellular therapies. Search Crunchbase. Start …See details»
F1 Oncology's International Affiliates and Sinobioway Sunterra ...
Jan 7, 2018 Shanghai Sinobioway Sunterra Biotechnology (“SSSB”) was formed by Sinobioway Group, Sunterra Capital and F1 Oncology for the express purpose of developing novel CAB …See details»
Shanghai Sinobioway Sunterra Biotechnology Venture Capital …
Shanghai Sinobioway Sunterra Biotechnology Co., Ltd., a company incorporated in Shanghai in 2016. Sinobioway Sunterra Biotechnology focuses on cutting-edge biotechnology, specifically …See details»
F1 Oncology Announces Development Milestone and …
Jan 7, 2018 Shanghai Sinobioway Sunterra Biotechnology ("SSSB") was formed by Sinobioway Group, Sunterra Capital and F1 Oncology for the express purpose of developing novel CAB-CAR-T therapies for solid tumor ...See details»
Shanghai Sinobioway Sunterra Biotechnology (Shanghai …
了解Shanghai Sinobioway Sunterra Biotechnology (Shanghai Sinobioway Sunterra Biotechnology)公司的药物管线，治疗领域，技术平台，以及它的2篇新闻。See details»
Shanghai Sinobioway Sunterra Biotechnology - ZoomInfo
Who is Shanghai Sinobioway Sunterra Biotechnology. Shanghai Sinobioway Sunterra Biotechnology is a company that operates in the Biotechnology industry. It employs 21-50 …See details»
Shanghai Sinobioway Sunterra Biotechnology - Updates, News, …
Shanghai Sinobioway Sunterra Biotechnology focuses on cutting-edge biotechnology, specifically in the field of adoptive cellular therapies.See details»
Shanghai Sinobioway Sunterra Biotechnology Co., Ltd - preqin.com
Founded in 2016 and based in Shanghai, China, Shanghai Sinobioway Sunterra Biotechnology Co., Ltd operates as a developer of novel therapies for the treatmen...See details»
Shanghai Sinobioway Sunterra Biotechnology - BioCentury …
Shanghai Sinobioway Sunterra Biotechnology - BioCentury Company Profiles for the biopharma industrySee details»
F1 Oncology’s International Affiliates and Sinobioway Sunterra ...
On January 7, 2018 Shanghai Sinobioway Sunterra Biotechnology (SSSB) and F1 Oncology reported the signing of new development, manufacturing, and supply agreements with plans to …See details»
Shanghai Sinobioway Sunterra Biotechnology - Crunchbase
Shanghai Sinobioway Sunterra Biotechnology has 1 current employee profile, Director and Founder Wu Zili. Contacts. Edit Contacts Section. We're working on getting contact data for …See details»
Sinobioway and F1 Oncology to Build Shenzhen CAR-T …
Jan 9, 2018 Shanghai Sinobioway Sunterra Biotech (SSSB) announced plans to extend its relationship with Florida's F1 Oncology. SSSB will build a production facility, called Shenzhen …See details»
Shanghai Sinobioway Sunterra Biotechnology: Drug pipelines, …
Jun 21, 2023 0 Patents (Medical) associated with Shanghai Sinobioway Sunterra Biotechnology. Login to view more data. Pipeline. Pipeline Snapshot as of 21 Jun 2023.See details»
List of CAR T-Cell Companies Worldwide 2024 - OneDayMD
Jun 23, 2024 BioAtla’s partner, Shanghai Sinobioway Sunterra Biotechnology, is undertaking a clinical trial for two novel, conditionally active chimeric antigen receptor T cell (CAB-CAR-T) …See details»
Sssb, f1 oncology sign new development, manufacturing & supply ...
Shanghai Sinobioway Sunterra Biotechnology (SSSB) and F1 Oncology announced the signing of the new development, manufacturing, and supply agreements with plans to complete a new …See details»
Shanghai Sinobioway Sunterra Biotechnology - Crunchbase
Shanghai Sinobioway Sunterra Biotechnology is actively using 6 technologies for its website, according to BuiltWith. These include Domain Not Resolving , Euro , and Content Delivery …See details»
SSSB and F1 oncology foray into Development, Manufacturing …
Jan 8, 2018 Shanghai Sinobioway Sunterra Biotechnology (SSSB) and F1 oncology initiate new development, manufacturing, and supply to finish a new cGMP manufacturing facility in …See details»